Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+,K+-pump in human mesenteric arteries

Journal of Hypertension

Volumn 16, Issue 12 SUPPL., 1998, Pages 1953-1958

  Bagrov, Alexie Y ^a   Fedorova, Olga V ^b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NONE

Author keywords

Bufodienolides; Inhibitors; Isoforms; Marinobufagenin; Na+K+ ATPase; Ouabain; Vascular smooth muscle

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTIBODY; DIGITALIS LIKE FACTOR; MARINOBUFAGENIN; NORADRENALIN; OUABAIN; PHENTOLAMINE; RUBIDIUM 86; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADRENERGIC SYSTEM; ADULT; ARTERY; BLOOD VESSEL TONE; CELL MEMBRANE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; MESENTERIC ARTERY; NERVE ENDING; NORADRENALIN RELEASE; PRIORITY JOURNAL; SARCOLEMMA; SUCROSE DENSITY GRADIENT CENTRIFUGATION; TECHNIQUE; VASCULAR RING; VASOCONSTRICTION; WESTERN BLOTTING;

EID: 0032436467     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816121-00015     Document Type: Conference Paper

References (35)

1. Sweadner KJ. Isozymes of Na,K-ATPaSe. Biochem Biophys Acta 1989; 988: 185-220.
2. Munzer JC, Daly SE, Jewell-Motz EA, Lingrel JB, Blostein R: Tissue- and isoform-specific kinetic behavior of the Na,K-ATPase. J Biol Chem 1994; 269: 16 668-16 676.
3. Berrebi-Bertrand I, Maixent J-M. Immunodetection and enzymatic characterization of the α3-isoform of Na,K-ATPase in the dog heart. FEBS Letters 1994; 348: 55-60.
4. Beauge L. Do Na,K-ATPase isoforms anchor where they must or where they can? News Physiol Sci 1993; 8: 239-240.
5. Tao Q-F, Hollenberg NK, Price DA, Graves SW. Sodium pump specificity for the digitalis-like factor isolated from human peritoneal dialysate. Hypertension 1996; 29: 815-821.
6. Fedorova OV, Bagrov AY. Inhibition of Na/K ATPase from rat aorta by two endogenous Na/K pump inhibitors, ouabain and marinobufagenin. Evidence of interaction with different α-subunit isoforms. Am J Hypertens 1997; 10: 929-935.
7. Ludens JH, Clark MA, Du Charme DW, Lutzke BS, Mandel F, Mathews WR, et al. Purification of an endogenous digitalislike factor from human plasma for structural analysis. Hypertension 1991; 17: 923-929.
8. Tymiak AA, Norman JA, Bolgar M, DiDonato GC, Lee H, Parker WL Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci USA 1993; 90: 8189-8193.
9. Lichtstein D, Gati I, Samuelov S, Berson D, Rosenman Y, Landau L, Deutsch J. Identification of digitalis-like compounds in human cataractous lenses. Eur J Biochem 1993; 216: 261-268.
10. Bagrov AY, Fedorova OV, Austin JL, Dmitrieva RI, Anderson DE. Endogenous marinobufagenin-like immunoreactive factor and Na,K-ATPase inhibition during voluntary hypoventilation. Hypertension 1995; 26: 781-788.
11. Sich B, Kirch U, Tepel M, Zidek W, Schoner W. Pulse pressure correlates in humans with a proscillaridin A immunoreactive compound. Hypertension 1996; 27: 1073-1077.
12. Hilton PJ, White RW, Lord GA, Garner GV, Gordon GB, Hilton MJ, et al. An inhibitor of the sodium pump obtained from human placenta. Lancet 1996; 348: 303-305.
13. Barbier M, Shroter H, Meyer K, Schindler O. Reichstein T. Die Bufogenine des Paratoidensekrets von Bufo marinus (L) Schneider. Helv Chim Acta 1959; 42: 2486-2506.
14. Bagrov AY, Fedorova OV, Dmitrieva RI, French AW, Anderson DE. Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anaesthetized dogs. Cardiovasc Res 1996; 31: 296-305.
15. Bagrov AY, Fedorova OV, Dmitrieva RI, Kazakov GP, Roukoyatkina NI, Shpen VM. Endogenous marinobufagenin-like immunoreactive substance: a possible endogenous Na,K-ATPase inhibitor with vasoconstrictor activity. Am J Hypertens 1996; 14: 1073-1079.
16. Bagrov AY, Fedorova OV, Dmitrieva RI, Howald WN, Hunter AP, Kuznetsova EA, Shpen VM. Bufodienolide nature of endogenous inhibitor of Na/K ATPase in the urine from patients with acute myocardial infarction. Hypertension 1998; 31: 1097-1103.
17. Fedorova OV, Doris PA, Bagrov AY. Endogenous marinobufagenin-like factor in acute plasma volume expansion. Clin Exp Hypertens 1998; 20: 581-591.
18. Bagrov AY, Roukoyatkina NI, Pinaev AG, Dmitrieva RI, Fedorova OV. Effects of two Na,K-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta. Eur J Pharmacol 1995, 274: 151-158.
19. Lin TH, Leitch IM, Boura LA, Read MA, Walters WAW: Effects of Bufo marinus skin toxins on human fetal extracorporeal blood vessels. Toxicon 1997; 35: 293-304.
20. Songu-Mize E, Bealer SL, Caldwell RW. Effect of AV3V lesions on development of DOCA-salt hypertension and vascular Na pump activity. Hypertension 1982; 4: 575-580.
21. Allen JC, Narvan SS, Kahn AM. Na-K-ATPase in vascular smooth muscle. Am J Physiol 1985; 250: C536-C539.
22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
23. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979, 76: 4350-4354.
24. Shyjan AW, Levenson W. Antisera specific for the α1, α2, α3, and β subunits of the Na,K-ATPase: differential expression of αand β subunits in rat tissue membranes. Biochemistry 1989 28: 4531-4535.
25. Pressley TA. Phylogenetic conservation of isoform-specific regions within α-subunit of Na-K-ATPase. Am J Physiol 1992; 262: C743-C751.
26. Zahler R, Sun W, Ardito T, Kashgarian M. Na-K-ATPase alpha-isoform expression in heart and vascular endothelia: cellular and developmental regulation. Am J Physiol 1996; 270: C361-C371.
27. Godfraind T, Castaneda Hernandez G, Ghysel Burton J, De Pover A. Hypothesis for the mechanism of stimulation of the Na/K pump by cardiac glycosides - role of endogenous digitalis-like factor. Curr Top Membr Transp 1983; 19: 913-915.
28. Smith TW, Barry WH. Monovalent cation transport and mechanisms of digitalis-induced inotropy. Curr Top Membr Transp 1983; 19: 857-884.
29. Vanhoutte PM, Lorenz RR. Na,K-ATPase inhibitors and the adrenergic neuroeffector interaction in the blood vessel wall. J Cardiovasc Pharmacol 1984; 6 (suppl 1), S88-S94.
30. 1-adrenergic events in rat and rabbit aorta. Pharmacology 1986; 33: 221-234.
31. Desilets M, Baumgarten CM. Isoproterenol directly stimulates the Na-K pump in isolated cardiac myocytes. Am J Physiol 1986; 251: H218-225.
32. Aperia A, Holtback U, Syren M-L, Svensson L-B, Fryckstedt J, Greengard P. Activation/deactivation of renal Na,K-ATPase: a final common pathway for regulation of natriuresis. FASEB J 1994; 8: 436-439.
33. Bagrov AY, Fedorova OV, Roukoyatkina NI, Zhabko EP. Effects of digoxinlike factor and digoxin antibody on myocardial Na,K-pump activity and ventrucular arrhythmias in acute myocardial ischaemia in rats. Cardiovasc Res 1993; 27: 1045-1050.
34. Daugherty A, Frayn KN, Redfern WS, Woodward B. The role of catecholamines in the production of ischaemia-induced ventricular arrhythmias in the rat in vivo and in vitro. Br J Pharmacol 1986; 87: 265-277.
35. Adams RJ, Wallick ET, Asano G, DiSalvo J, Foncardo JD, Jacobson ED. Canine mesenteric artery Na,K-ATPase: vasopressor receptor for digitalis? J Cardiovasc Pharmacol 1983; 5: 468-482.